Sherkow talks about Myriad’s importance a decade later

Association for Molecular Pathology v. Myriad Genetics, Inc. was a cultural phenomenon when the Supreme Court’s ruling was issued, with the outcome taking a place on the front-page of most major newspapers in the United States. Reflecting more than 10 years on from the decision, however, Professor Jacob Sherkow tells the Carl R. Woese Institute for Genomic Biology that the Myriad decision ended up having little impact on biotechnology research. 

Nature quotes Sherkow on researcher who treated her own cancer

Self-treatment is a risky and controversial choice, as detailed in a new Nature article about a cancer researcher who decided to do research and treat her own breast cancer. In the article, Professor Jacob Sherkow is quoted about the dangers of publishing this kind of work; his comments are also included in a story for Futurism.

Read both the Nature article and the Futurism article online.

Sherkow presents before New York Intellectual Property Law Association

In September, Professor Jacob Sherkow delivered a presentation on the legal aspects of DNA sequencing cases to the New York Intellectual Property Law Association. His presentation, titled “Trade Secrets Committee Meeting: Litigating DNA Trade Secrecy,” covered whether DNA sequences are protectable by trade secrecy and if recent advances in DNA sequencing technology might destroy trade secrecy protection for certain kinds data. He reviewed the technology in the field and cases focused on DNA trade secrecy as well as provided practical suggestions for litigating DNA trade secrecy cases.

Sherkow publishes new paper on Myriad decision

A decade on from the U.S. Supreme Court’s decision in Association for Molecular Pathology v. Myriad Genetics, Inc., Professor Jacob Sherkow argues that what seemed like a political and cultural phenomenon has had a much narrower impact. Writing as the first author in a new paper published in Annual Review of Genomics and Human Genetics, Sherkow explains how the Myriad decision has had a modest impact on patents, largely hidden by other developments in science and law since the case was decided.

BioSpace quotes Sherkow on CRISPR patent dispute

The patent battle over CRISPR-Cas9 technology has gone on for longer than a decade, but continues to wind its way through the courts. The global CRISPR-Cas9 gene-editing market size is expected to grow to $14.65 billion by 2032, and Professor Jacob Sherkow told BioSpace that companies seeking to license the technology may be content to wait and see how the patent battle settles rather than rushing to pay now. “If you get that wrong, that is a lot of money you set on fire,” Sherkow said.

STAT quotes Sherkow on pharmaceutical patents

The practice of using “patent thickets,” which allow pharmaceutical companies to delay low-cost generic medicines reaching the market, is being targeted by a rule change proposed by the U.S. Patent and Trademark Office. The change would reduce the number of terminal disclaimers, an important part of patent thickets, which offers the potential to speed the entry of generic drugs to the market, Professor Jacob Sherkow explained to STAT. He cautioned, however, that companies may still find clever ways to skirt the rules.

Sherkow authors new article on DNA trade secrecy

Whether or not DNA sequences are subject to trade secrecy protections is the critical question examined by Professor Jacob Sherkow in his latest article, published in the Hastings Law Journal. Despite decades of scholarship assuming DNA sequences would be subject to protection, recent research has suggested this assumption was incorrect. Sherkow explores why DNA sequences might not be protected as well as the implications of this change.

Sherkow receives prestigious recognition as University Scholar

Professor Jacob Sherkow is one of only five University of Illinois Urbana-Champaign professors to be named a University Scholar in recognition of his excellence in teaching, scholarship and service. 

The scholars program recognizes faculty excellence and provides $15,000 to each scholar for three years to enhance their academic careers. The money may be used for travel, equipment, research assistants, books or other purposes.

“The University Scholars program celebrates the remarkable achievements of the named individuals,” said Nicholas Jones, the University of Illinois System’s executive vice president and vice president for academic affairs. “Our faculty represent the strong foundation of the world-class academic experience that contributes to the betterment of society and draws students and researchers to the U. of I. System universities from across the globe. The University Scholars are exemplars of that faculty excellence. 

“When you consider the diversity of scholarship across all three of our universities and the standards of academic excellence that we nurture and grow through our recruitment of esteemed educators and researchers, all of our University Scholar recipients should be deservedly proud of the honor.”

Sherkow publishes chapter in COVID-19 and the Law

Professor Jacob Sherkow is one of the authors of a chapter in the new book “COVID-19 and the Law,” published by Cambridge University Press. The chapter examines the ways in which aspects of health law such as food and drug regulation, healthcare reimbursement, and direct research and development subsidies encouraged and impeded new technologies in the fight against COVID-19. The authors sought to provide insight to highlight important lessons for policymakers in order to better prepare for the next pandemic.

Politico quotes Sherkow on CRISPR case

The dispute over who invented CRISPR-Cas9 gene editing is headed to federal appellate court, and Politico turned to Professor Jacob Sherkow to help sort out the details. He expects the case will return to patent court and may result in changes to the licensing fees collected. “Absolutely none of this under any reasonable interpretation is going to change what the retail sticker cost of these drug therapies are going to be — not by a dollar, not by a cent,” Sherkow added.

College of Law
504 East Pennsylvania Avenue
Champaign, IL 61820
(217) 333-0931